Amicus Therapeutics is establishing a new Global Research and Gene Therapy Center of Excellence in Philadelphia, PA, to advance its commitment to rare metabolic diseases. The new 75,000 sq. ft. center will be completed in the second half of 2019 and will serve as the headquarters for the global Amicus science organization and the gene therapy leadership team. Amicus expects up to 200 employees to eventually be based at the new Philadelphia facility. The Company is maintaining global business ope...